Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
暂无分享,去创建一个
A. Bezjak | J. V. van Meerbeeck | C. Faivre-Finn | P. Lorigan | P. Woll | F. Blackhall | S. Harden | J. Pantarotto | F. Barlesi | P. Fournel | C. Le Péchoux | M. O'Brien | R. McMenemin | F. Cardenal | M. Snee | V. Surmont | L. Ashcroft | A. Bhatnagar | N. Mohammed | W. Appel | R. Mcmenemin